N-Acetyl Selank is a chemically modified analog of the Selank heptapeptide sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. AZOTH’s current product language describes an N-terminal acetyl modification and C-terminal amidation; those terminal modifications should be confirmed against the lot-specific identity data and used consistently across the page and COA.
Terminal acetylation and amidation are common peptide-engineering strategies used to alter charge state and susceptibility to exopeptidases.
Scientific / Analytical Profile
- Core sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
- Reported modifications: N-terminal acetylation and C-terminal amidation; verify against batch COA
- Class: modified synthetic heptapeptide research material
- Analytical focus: terminal modification, intact mass, purity, stability, and degradation
- Research positioning: non-clinical peptide chemistry and assay development
Batch-specific identity, purity, and analytical results should be confirmed against the applicable Certificate of Analysis and lot documentation.
Research Use Only. This material is intended solely for controlled laboratory, analytical, and scientific research. It is not for human or veterinary use or administration, diagnosis, treatment, prevention, cosmetic use, food use, or personal use.
